Study Comparing Isolated Pelvic Perfusion With TNF-α 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer
Clinical trial NCT00949039 · COMPLETED
Trial details
- NCT number
- NCT00949039
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2014-03-01
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.